Well, in the approximately 2 days from my initial inquiry on the clarification of statements made in section 4.22 of the loan documents, and specifically asking to clarify about whether Resverlogix is still blinded in BETonMACE and whether "to date relative risk reduction" data was made available to Resverlogix and/or Third Eye Capital, Sarah's response to me this afternoon was:

"Resverlogix adheres to a high standard Disclosure Policy. The Company is in compliance with proper disclosure methods."

I replied back:

"I was hoping for a little more detail. Is Resverlogix still blinded to the BETonMACE trial results? Section 4.22 was ambigous. Has Third Eye Capital been made aware of the relative risk reduction to date in BETonMACE as implied in 4.22(x)?"

Are these fair and simple questions to ask?

BDAZ